Влияние мезенхимальных стромальных клеток на клинико-лабораторные показатели эффективности трансплантации аутологичных гемопоэтических стволовых клеток у больных лимфомами
Баторов Егор Васильевич, Е. Ya. Shevela, Крючкова Ирина Валентиновна et al. · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · 2012
The clinical and laboratory effects of bone-marrow derived mesenchymal stromal cells (MSC) in patients with malignant lymphomas following autologous hematopoietic stem cell transplantation (auto-HSCT) have been investigated. Co-transplantation of MSC in average dose of 0,178 10 6/kg was conducted in 74 patients with auto-HSCT. The control group included 83 patients eligible for standard HSCT. We revealed the decreasing of the period of neutropenia and thrombocytopenia when hematopoietic stem cells were co-transplanted with low doses ex vivo expanded autologous MSC. Patients with MSC co-transplantation were differed by more effective early lymphocyte recovery. At the same time MSC co-transplantation did not increase the incidence of infectious complications and cases of renal and. hepatic toxicity. Patients with MSC co-transplantation did not differ from opposite group by 5-year overall survival, but were characterized by significantly better progression-free survival.
Cited by 0 works.